Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bali Pulendran

Showing results (251-260 of 262) with videos related to

Pageof 27
Sort By:
Communications Medicine|January 3, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Communications Medicine|February 23, 2026
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Frontiers in Medicine|July 21, 2025
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC studyJintong Hou, Benjamin Haslund-Gourley, Joann Diray-Arce, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19Cole Maguire, Jing Chen, Nadine Rouphael, et al.
Nature|April 19, 2021
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
The Journal of Clinical Investigation|September 9, 2025
A multiomics recovery factor predicts long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
Nature Microbiology|March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Critical Care (London, England)|October 15, 2025
Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDSAna C Costa Monteiro, Harry Pickering, Aartik Sarma, et al.
JCI Insight|May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Pageof 27

Showing results (251-260 of 262) with videos related to

Sort By:
Pageof 27
Communications Medicine|January 3, 2026
Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Communications Medicine|February 23, 2026
Author Correction: Machine learning models predict long COVID outcomes based on baseline clinical and immunologic factorsNaresh Doni Jayavelu, Hady Samaha, Sonia Tandon Wimalasena, et al.
Frontiers in Medicine|July 21, 2025
Baseline predictors for 28-day COVID-19 severity and mortality among hospitalized patients: results from the IMPACC studyJintong Hou, Benjamin Haslund-Gourley, Joann Diray-Arce, et al.
Biorxiv : the Preprint Server for Biology|November 28, 2024
Chronic Viral Reactivation and Associated Host Immune Response and Clinical Outcomes in Acute COVID-19 and Post-Acute Sequelae of COVID-19Cole Maguire, Jing Chen, Nadine Rouphael, et al.
Nature|April 19, 2021
Adjuvanting a subunit COVID-19 vaccine to induce protective immunityPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
The Journal of Clinical Investigation|September 9, 2025
A multiomics recovery factor predicts long COVID in the IMPACC studyGisela Gabernet, Jessica Maciuch, Jeremy P Gygi, et al.
Nature Microbiology|March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
Biorxiv : the Preprint Server for Biology|February 17, 2021
Adjuvanting a subunit SARS-CoV-2 nanoparticle vaccine to induce protective immunity in non-human primatesPrabhu S Arunachalam, Alexandra C Walls, Nadia Golden, et al.
Critical Care (London, England)|October 15, 2025
Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDSAna C Costa Monteiro, Harry Pickering, Aartik Sarma, et al.
JCI Insight|May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Pageof 27